Alector, Inc. (ALEC) vs Eledon Pharmaceuticals, Inc. (ELDN)
A side-by-side comparison of Alector, Inc. and Eledon Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALEC
Alector, Inc.
$1.92HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
ELDN
Eledon Pharmaceuticals, Inc.
$2.53HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ALEC vs ELDN
growth of $100 · dividends reinvested · last 8yALEC -88.9% (-24.1%/yr)ELDN -96.6% (-34.5%/yr)ALEC compounded faster over this window
ALEC ELDN
ALEC vs ELDN: by the numbers
- •ALEC is the larger company ($213M vs $195M market cap).
- •Both run net losses; ELDN's is the smaller (0.00% vs -850.13% net margin).
Metrics side by side
Valuation
| Metric | ALEC | ELDN |
|---|---|---|
| P/S ratio | 15.38 | N/A |
| P/B ratio | N/A | 5.92 |
Profitability
| Metric | ALEC | ELDN |
|---|---|---|
| Gross margin | 54.09% | 0.00% |
| Operating margin | -692.83% | 0.00% |
| Net margin | -850.13% | 0.00% |
| ROE | N/A | -136.83% |
| ROIC | -71.04% | -74.02% |
Growth (annualized)
| Metric | ALEC | ELDN |
|---|---|---|
| Revenue CAGR (5Y) | -8.35% | N/A |
| Total return CAGR (5Y) | -39.17% | -15.17% |
Frequently asked
- How have ALEC and ELDN total returns compared?
- Over the past 5 years, ALEC delivered -39.17% and ELDN delivered -15.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.